The Intestinal Microbiome in Early Life: Health and Disease
Кишечный микробиом в раннем возрасте: здоровье и болезни
2014-09-05
SCID: 54.1/qvt536hb
Discuss with AI
early-life gut microbiomegut microbial dysbiosisimmune developmentimmune-mediated disease (IBD, asthma)metabolic disease (obesity)
Figures from the paper
Abstract (AI)
Human microbial colonization begins at birth and continues to develop and modulate in species abundance for about 3 years, until the microbiota becomes adult-like. During the same time period, children experience significant developmental changes that influence their health status as well as their immune system. An ever-expanding number of articles associate several diseases with early-life imbalances of the gut microbiota, also referred to as gut microbial dysbiosis. Whether early-life dysbiosis precedes and plays a role in disease pathogenesis, or simply originates from the disease process itself is a question that is beginning to be answered in a few diseases, including IBD, obesity, and asthma. This review describes the gut microbiome structure and function during the formative first years of life, as well as the environmental factors that determine its composition. It also aims to discuss the recent advances in understanding the role of the early-life gut microbiota in the development of immune-mediated, metabolic, and neurological diseases. A greater understanding of how the early-life gut microbiota impacts our immune development could potentially lead to novel microbial-derived therapies that target disease prevention at an early age.
Key Findings
1
Early-life gut microbiota composition coincides with critical childhood developmental changes that influence immune system development and health.
2
For some diseases (IBD, obesity, asthma), evidence is emerging that early-life dysbiosis may precede and contribute to disease pathogenesis rather than only result from disease.
3
Human gut microbiota colonization begins at birth and develops into an adult-like composition over about three years.
4
Numerous studies associate early-life gut microbial dysbiosis with later diseases, including inflammatory bowel disease (IBD), obesity, and asthma.
5
Understanding early-life gut microbiota could enable development of microbial-derived preventive therapies targeting immune-mediated, metabolic, and neurological diseases.
Research Object
Early-life human intestinal (gut) microbiome
Research Subject
How composition, structure, and development of the early-life gut microbiota influence health and disease risk, including roles in immune development and in immune-mediated, metabolic, and neurological disorders
Publication Details
Publication Date
2014-09-05
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest